Imricor Medical Systems, Inc. announced it has received a grant award of USD 1.158 million from the North Dakota Department of Agriculture as part of the department's Bioscience Innovation Grant (BIG) program. The grant funds will support the Company's remaining US approval process, including the VISABL-AFL clinical trial and the subsequent FDA review.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 AUD | 0.00% | -5.77% | -14.04% |
Apr. 11 | Imricor Medical Systems Secures First Catheter Order from Croatia's Dubrava University Hospital | MT |
Apr. 10 | Mining, Healthcare Stocks Lift Australian Benchmark | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.04% | 64.73M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+2.13% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Imricor Medical Systems, Inc. Receives USD 1.158 Million Grant